Clinical Trials Browser

Phase 2 × Uveal Melanoma × cediranib × Clear all

NCT04184518 2020-06-02

CEDUVEAL-M

Phase 2 Withdrawn

Uveal Melanoma, Neoplasm Metastasis

NCT00243061 2018-08-27

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Phase 2 Completed

24 enrolled 12 charts

Uveal Melanoma, Melanoma